BioHistory Moment: Diamond v. Chakrabarty case argued before U.S. Supreme Court

On March 17, 1980, the Diamond v. Chakrabarty case was argued before the U.S. Supreme Court regarding the patentability of genetically altered microorganisms.

In 1972, Chakrabarty filed a patent application assigned to the General Electric Co. for a human-made genetically engineered bacterium capable of breaking down multiple components of crude oil. The application asserted 36 claims related to Chakrabarty's invention of a bacterium from the genus Pseudomonas containing at least two stable energy-generating plasmids, each of said plasmids providing a separate hydrocarbon degradative pathway.

On June 16, 1980, the U.S. Supreme Court upheld five-to-four the patentability of genetically altered organisms, opening the door to greater patent protection for any modified life forms. Opinions: Chief Justice Warren Burger delivered the opinion of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and John Paul Stevens joined. William Brennan filed the dissenting opinion, in which Byron White, Thurgood Marshall, and Lewis Powell joined.

Learn about Seattle's PNDRI Life Sciences Incubator Building

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in British Columbia, regionally or nationwide.

Industry News...

Free News Release Posting & Archiving Service


• Abbott statement: ACCORD lipid results support treatment guidelines for fibrate use  Results presented on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies - glycemic control, blood pressure control and lipid control.
  Abbott  March 14, 2010  
  
  
• Data demonstrates Abbott's MitraClip has potential to be a valuable treatment option  Data from the EVEREST II trial demonstrated that Abbott's investigational MitraClip® system met both its primary safety and effectiveness endpoints, suggesting the minimally invasive MitraClip procedure may be an important treatment option for patients with significant mitral regurgitation.
  Abbott  March 14, 2010  
  
  
• FDA announces new boxed warning on Plavix  The U.S. Food and Drug Administration added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form.
  FDA  March 12, 2010  
  
  
• Sanofi-aventis and BMS announce important updates to PLAVIX U.S. prescribing info  Sanofi-aventis U.S. and Bristol-Myers Squibb announced revisions to the U.S. prescribing information for PLAVIX(R) (clopidogrel bisulfate), which include a boxed warning.
  Bristol-Myers Squibb Company  March 12, 2010  
  
  
• Monsanto welcomes chance to participate in Dept. of Justice/Dept. of Agriculture workshop  As part of today's first joint public workshop exploring competition issues in the agriculture industry, Monsanto will participate in a panel discussion about the past, present and future of the seed and trait industry.
  Monsanto Company  March 12, 2010  
  
  

More... | Submit News Release | Advertising...

New Job Postings...

Free Job Posting Trial Offer

• Business Development Associate Integrated Diagnostics, Inc. (WA)
• Corporate Communications Specialist Seattle Genetics, Inc. (WA)
• Senior Research Associate Dendreon Corporation (WA)
• Scientist II/SR Dendreon Corporation (WA)
• Research Scientist, Medicinal Chemistry Gilead Sciences (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• 890 Embarcadero Road Property -- West Sacramento, CA
• CompleGen Lab/Office Space -- Seattle, WA
• Life Sciences Incubator -- Seattle, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

• 03/15/2010: Pharmacovigilance
• 03/16/2010: ORCA Monthly Meeting: Requirements & Best Practices for Management Review (Part 3 of 4 in Medical Device Quality System Series)
• 03/16/2010: Pharma & Biotech Supply Chain Asia 2010
• 03/16/2010: Global health as an Investment Opportunity
• 03/16/2010: Preparing an R&D Product for Out-Licensing and Due Diligence

More... | Submit Event | Event Advertising...